Startups

PerturbAI

Combines large-scale in-vivo CRISPR experiments with AI to map how disease genes affect cells and biological circuits, then uses those causal measurements to discover therapeutic targets.

Team

Grace ZhengCo-Founder and CEO

Xin JinCo-Founder

Investments

$—Unknown date

Matter Venture Partners